Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Response of high-risk MDS to azacitidine and lenalidomide is impacted by baseline and acquired mutations in a cluster of three inositide-specific genes
Matilde Y. Follo, Andrea Pellagatti, Richard N. Armstrong, et al.
Leukemia (2019) Vol. 33, Iss. 9, pp. 2276-2290
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

The role of PLCγ2 in immunological disorders, cancer, and neurodegeneration
Jacob T. Jackson, Elisabeth Mulazzani, Stephen L. Nutt, et al.
Journal of Biological Chemistry (2021) Vol. 297, Iss. 2, pp. 100905-100905
Open Access | Times Cited: 75
Phospholipase C families: Common themes and versatility in physiology and pathology
Matilda Katan, Shamshad Cockcroft
Progress in Lipid Research (2020) Vol. 80, pp. 101065-101065
Open Access | Times Cited: 71
Overarching roles of diacylglycerol signaling in cancer development and antitumor immunity
Mariana Cooke, Marcelo G. Kazanietz
Science Signaling (2022) Vol. 15, Iss. 729
Closed Access | Times Cited: 49
Phosphoinositide-Dependent Signaling in Cancer: A Focus on Phospholipase C Isozymes
Eric Owusu Obeng, Isabella Rusciano, Maria Vittoria Marvi, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 7, pp. 2581-2581
Open Access | Times Cited: 69
Deciphering signaling pathways in hematopoietic stem cells: the molecular complexity of Myelodysplastic Syndromes (MDS) and leukemic progression
Irene Casalin, Alessia De Stefano, Eleonora Ceneri, et al.
Advances in Biological Regulation (2024) Vol. 91, pp. 101014-101014
Open Access | Times Cited: 4
SMC2 and Condensin II Subunits Are Essential for the Development of Hematopoietic Stem and Progenitor Cells in Zebrafish
Chang‐Kyu Oh, Man S. Kim, Unbeom Shin, et al.
Journal of Cellular Physiology (2025) Vol. 240, Iss. 3
Open Access
Prediction of Alzheimer’s disease-specific phospholipase c gamma-1 SNV by deep learning-based approach for high-throughput screening
Sung-Hyun Kim, Sumin Yang, Key‐Hwan Lim, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 3
Open Access | Times Cited: 24
Phospholipase Cγ2 regulates endocannabinoid and eicosanoid networks in innate immune cells
Hui Jing, Alex Reed, Olesya A. Ulanovskaya, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 41
Open Access | Times Cited: 22
The Genomics of Myelodysplastic Syndromes: Origins of Disease Evolution, Biological Pathways, and Prognostic Implications
Hassan Awada, Bicky Thapa, Valeria Visconte
Cells (2020) Vol. 9, Iss. 11, pp. 2512-2512
Open Access | Times Cited: 18
Gene mutations and clonal architecture in myelodysplastic syndromes and changes upon progression to acute myeloid leukaemia and under treatment
Juliane M. Stosch, Anezka Heumüller, Christoph Niemöller, et al.
British Journal of Haematology (2018) Vol. 182, Iss. 6, pp. 830-842
Open Access | Times Cited: 18
Nuclear Inositides and Inositide-Dependent Signaling Pathways in Myelodysplastic Syndromes
Jie Xian, Eric Owusu Obeng, Stefano Ratti, et al.
Cells (2020) Vol. 9, Iss. 3, pp. 697-697
Open Access | Times Cited: 12
Cryptic mutations of PLC family members in brain disorders: recent discoveries and a deep-learning-based approach
Key‐Hwan Lim, Sumin Yang, Sung‐Hyun Kim, et al.
Brain (2022) Vol. 146, Iss. 4, pp. 1267-1280
Open Access | Times Cited: 7
Glycogen Synthase Kinase-3 and phospholipase C-beta signalling: Roles and possible interactions in myelodysplastic syndromes and acute myeloid leukemia
Stefano Ratti, Sara Mongiorgi, Isabella Rusciano, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2020) Vol. 1867, Iss. 4, pp. 118649-118649
Open Access | Times Cited: 9
Recent advances in MDS mutation landscape: Splicing and signalling
Matilde Y. Follo, Andrea Pellagatti, Stefano Ratti, et al.
Advances in Biological Regulation (2019) Vol. 75, pp. 100673-100673
Open Access | Times Cited: 9
A miRNA screening identifies miR-192-5p as associated with response to azacitidine and lenalidomide therapy in myelodysplastic syndromes
Sara Mongiorgi, Alessia De Stefano, Stefano Ratti, et al.
Clinical Epigenetics (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Multi-omics analysis of multiple myeloma patients with differential response to first-line treatment
Bo Zheng, Ke Yi, Yajun Zhang, et al.
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 7, pp. 3833-3846
Closed Access | Times Cited: 3
Inositide-Dependent Nuclear Signalling in Health and Disease
Matilde Y. Follo, Stefano Ratti, Lucia Manzoli, et al.
Handbook of experimental pharmacology (2019), pp. 291-308
Closed Access | Times Cited: 6
Phospholipase C beta1 (PI‐PLCbeta1)/Cyclin D3/protein kinase C (PKC) alpha signaling modulation during iron‐induced oxidative stress in myelodysplastic syndromes (MDS)
Alessandra Cappellini, Sara Mongiorgi, Carlo Finelli, et al.
The FASEB Journal (2020) Vol. 34, Iss. 11, pp. 15400-15416
Open Access | Times Cited: 6
“Modulating Phosphoinositide Profiles as a Roadmap for Treatment in Acute Myeloid Leukemia”
Stefano Ratti, Camilla Evangelisti, Sara Mongiorgi, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 6
Azacitidine regulates DNA methylation of GADD45γ in myelodysplastic syndromes
Yanli Yang, Jun Li, Ying-Hua Geng, et al.
Journal of Clinical Laboratory Analysis (2020) Vol. 35, Iss. 2
Open Access | Times Cited: 5
Efficacy of lenalidomide for relapsed or refractory T lymphoblastic lymphoma/leukemia after allogeneic hematopoietic stem cell transplantation
Dan Liang, Cong Wei, Xiaoting Zhang, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2021) Vol. 62, Iss. 10, pp. 2521-2525
Closed Access | Times Cited: 5
Gene Expression Profiles Identify Biomarkers of Resistance to Decitabine in Myelodysplastic Syndromes
Seungyoun Kim, Dong‐Yeop Shin, Dayeon Kim, et al.
Cells (2021) Vol. 10, Iss. 12, pp. 3494-3494
Open Access | Times Cited: 4
Advances in MDS/AML and inositide signalling
Alessia De Stefano, Maria Vittoria Marvi, Antonietta Fazio, et al.
Advances in Biological Regulation (2023) Vol. 87, pp. 100955-100955
Open Access | Times Cited: 1
Current status of pretransplant intensive chemotherapy or hypomethylating agents for myelodysplastic syndrome
Christian Niederwieser, Nicolaus Kröger
Best Practice & Research Clinical Haematology (2021) Vol. 34, Iss. 4, pp. 101332-101332
Closed Access | Times Cited: 3
Crosstalk between phospholipases and noncoding RNAs in cancer
Shreya Baisakhiya, SunilGowda Sunnaghatta Nagaraja, Devipriya Nagarajan
Elsevier eBooks (2023), pp. 405-427
Closed Access
Page 1 - Next Page

Scroll to top